These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

543 related items for PubMed ID: 19702724

  • 1. Serum concentrations and tissue expression of a novel endocrine regulator fibroblast growth factor-21 in patients with type 2 diabetes and obesity.
    Mraz M, Bartlova M, Lacinova Z, Michalsky D, Kasalicky M, Haluzikova D, Matoulek M, Dostalova I, Humenanska V, Haluzik M.
    Clin Endocrinol (Oxf); 2009 Sep; 71(3):369-75. PubMed ID: 19702724
    [Abstract] [Full Text] [Related]

  • 2. Serum preadipocyte factor-1 concentrations in females with obesity and type 2 diabetes mellitus: the influence of very low calorie diet, acute hyperinsulinemia, and fenofibrate treatment.
    Kavalkova P, Touskova V, Roubicek T, Trachta P, Urbanova M, Drapalova J, Haluzikova D, Mraz M, Novak D, Matoulek M, Lacinova Z, Haluzik M.
    Horm Metab Res; 2013 Oct; 45(11):820-6. PubMed ID: 23979788
    [Abstract] [Full Text] [Related]

  • 3. The obestatin receptor (GPR39) is expressed in human adipose tissue and is down-regulated in obesity-associated type 2 diabetes mellitus.
    Catalán V, Gómez-Ambrosi J, Rotellar F, Silva C, Gil MJ, Rodríguez A, Cienfuegos JA, Salvador J, Frühbeck G.
    Clin Endocrinol (Oxf); 2007 Apr; 66(4):598-601. PubMed ID: 17371481
    [Abstract] [Full Text] [Related]

  • 4. Changes of endocrine function of adipose tissue in anorexia nervosa: comparison of circulating levels versus subcutaneous mRNA expression.
    Dolezalova R, Lacinova Z, Dolinkova M, Kleiblova P, Haluzikova D, Housa D, Papezova H, Haluzik M.
    Clin Endocrinol (Oxf); 2007 Nov; 67(5):674-8. PubMed ID: 17953628
    [Abstract] [Full Text] [Related]

  • 5. [The influence of very-low-calorie diet on soluble adhesion molecules and their gene expression in adipose tissue of obese women].
    Bosanská L, Lacinová Z, Roubícek T, Mráz M, Bártlová M, Dolezalová R, Housová J, Kremen J, Haluzíková D, Matoulek M, Haluzík M.
    Cas Lek Cesk; 2008 Nov; 147(1):32-7. PubMed ID: 18323040
    [Abstract] [Full Text] [Related]

  • 6. Association of impaired glucose metabolism in morbid obesity with hypoadiponectinaemia.
    Schinner S, Kempf K, Overmann H, Willenberg HS, Schott M, Rose B, Scherbaum WA, Herder C.
    Exp Clin Endocrinol Diabetes; 2008 Sep; 116 Suppl 1():S64-9. PubMed ID: 18777458
    [Abstract] [Full Text] [Related]

  • 7. [The influence of obesity on the gene expression of adiponectin and its receptor in subcutaneous adipose tissue].
    Lacinová Z, Michalský D, Kasalický M, Dolinková M, Haluzíková D, Roubícek T, Krajícková J, Mráz M, Matoulek M, Haluzík M.
    Vnitr Lek; 2007 Nov; 53(11):1190-7. PubMed ID: 18277629
    [Abstract] [Full Text] [Related]

  • 8. Serum fibroblast growth factor 21 was elevated in subjects with type 2 diabetes mellitus and was associated with the presence of carotid artery plaques.
    An SY, Lee MS, Yi SA, Ha ES, Han SJ, Kim HJ, Kim DJ, Lee KW.
    Diabetes Res Clin Pract; 2012 May; 96(2):196-203. PubMed ID: 22293928
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Serum concentrations and tissue expression of components of insulin-like growth factor-axis in females with type 2 diabetes mellitus and obesity: the influence of very-low-calorie diet.
    Touskova V, Trachta P, Kavalkova P, Drapalova J, Haluzikova D, Mraz M, Lacinova Z, Marek J, Haluzik M.
    Mol Cell Endocrinol; 2012 Sep 25; 361(1-2):172-8. PubMed ID: 22548717
    [Abstract] [Full Text] [Related]

  • 11. Monocyte chemoattractant protein-1 in obesity and type 2 diabetes. Insulin sensitivity study.
    Chacón MR, Fernández-Real JM, Richart C, Megía A, Gómez JM, Miranda M, Caubet E, Pastor R, Masdevall C, Vilarrasa N, Ricard W, Vendrell J.
    Obesity (Silver Spring); 2007 Mar 25; 15(3):664-72. PubMed ID: 17372317
    [Abstract] [Full Text] [Related]

  • 12. The effect of very-low-calorie diet on mRNA expression of inflammation-related genes in subcutaneous adipose tissue and peripheral monocytes of obese patients with type 2 diabetes mellitus.
    Mraz M, Lacinova Z, Drapalova J, Haluzikova D, Horinek A, Matoulek M, Trachta P, Kavalkova P, Svacina S, Haluzik M.
    J Clin Endocrinol Metab; 2011 Apr 25; 96(4):E606-13. PubMed ID: 21289263
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Long-term beneficial effect of a 16-week very low calorie diet on pericardial fat in obese type 2 diabetes mellitus patients.
    Snel M, Jonker JT, Hammer S, Kerpershoek G, Lamb HJ, Meinders AE, Pijl H, de Roos A, Romijn JA, Smit JW, Jazet IM.
    Obesity (Silver Spring); 2012 Aug 25; 20(8):1572-6. PubMed ID: 22282049
    [Abstract] [Full Text] [Related]

  • 15. Serum fibroblast growth factor 21 levels in gestational diabetes mellitus in relation to insulin resistance and dyslipidemia.
    Stein S, Stepan H, Kratzsch J, Verlohren M, Verlohren HJ, Drynda K, Lössner U, Blüher M, Stumvoll M, Fasshauer M.
    Metabolism; 2010 Jan 25; 59(1):33-7. PubMed ID: 19699495
    [Abstract] [Full Text] [Related]

  • 16. Conjugated linoleic acid induces hepatic expression of fibroblast growth factor 21 through PPAR-α.
    Yu J, Yu B, Jiang H, Chen D.
    Br J Nutr; 2012 Feb 25; 107(4):461-5. PubMed ID: 21767451
    [Abstract] [Full Text] [Related]

  • 17. Fibroblast growth factor 21 levels are increased in nonalcoholic fatty liver disease patients and are correlated with hepatic triglyceride.
    Li H, Fang Q, Gao F, Fan J, Zhou J, Wang X, Zhang H, Pan X, Bao Y, Xiang K, Xu A, Jia W.
    J Hepatol; 2010 Nov 25; 53(5):934-40. PubMed ID: 20675007
    [Abstract] [Full Text] [Related]

  • 18. Serum concentrations of fibroblast growth factor 19 in patients with obesity and type 2 diabetes mellitus: the influence of acute hyperinsulinemia, very-low calorie diet and PPAR-α agonist treatment.
    Mráz M, Lacinová Z, Kaválková P, Haluzíková D, Trachta P, Drápalová J, Hanušová V, Haluzík M.
    Physiol Res; 2011 Nov 25; 60(4):627-36. PubMed ID: 21574752
    [Abstract] [Full Text] [Related]

  • 19. Serum FGF21 levels are increased in newly diagnosed type 2 diabetes with nonalcoholic fatty liver disease and associated with hsCRP levels independently.
    Li X, Fan X, Ren F, Zhang Y, Shen C, Ren G, Sun J, Zhang N, Wang W, Ning G, Yang J.
    Diabetes Res Clin Pract; 2011 Jul 25; 93(1):10-6. PubMed ID: 21596453
    [Abstract] [Full Text] [Related]

  • 20. FGF21: a novel prospect for the treatment of metabolic diseases.
    Kharitonenkov A, Shanafelt AB.
    Curr Opin Investig Drugs; 2009 Apr 25; 10(4):359-64. PubMed ID: 19337957
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 28.